SubjectWell Expands Its Clinical Trials Marketplace to United Kingdom, Ireland, and South Africa
/– SubjectWell announced it is expanding its risk-free clinical trials marketplace into the United Kingdom, Ireland and South Africa.
– With 86% of clinical trials operating sites outside of the U.S., the company continues to develop a more streamlined and complete risk-free patient recruitment offering, now with global reach.
SubjectWell, an Austin, TX-based risk-free clinical trials marketplace announced it has expanded its patient recruitment services into the United Kingdom, Ireland, and South Africa. Supplementing its current footprint in the U.S. and Canada, the expansion is part of SubjectWell’s efforts to meet the needs of its pharmaceutical and clinical trial sponsors running global clinical trials, all while continuing to accelerate last patient in (LPI) by increasing awareness of clinical research in the general population and only charging for those patients who randomize.